Status:
UNKNOWN
Visual Study of Molecular Genotype in Glioma Evolution
Lead Sponsor:
Tongji Hospital
Conditions:
Glioma of Brain
Eligibility:
All Genders
Brief Summary
The key molecular changes in the progression of glioma are closely related to tumor heterogeneity, pathological grade, precision treatment and prognosis of glioma. At present, a visually quantitative ...
Eligibility Criteria
Inclusion
- postoperative pathological and genetic test confirmed brain glioma;
- The preoperative Clear and complete multimodal imaging data were collected within 10 days.
Exclusion
- patients who underwent surgery more than 4 weeks after MRI;
- patients with motion artifacts.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03750890
Start Date
January 1 2019
End Date
December 31 2022
Last Update
March 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhenxiong Wang
Wuhan, Choose A State Or Province, China, 430030